Explore our resources
Webinar
Johnson & Johnson’s Open Source Journey in R
Johnson & Johnson is charting a new path for clinical trial submissions; one built on transparency, efficiency, and collaboration through open-source tooling and R.
Webinar
The Power of Snowflake and Posit Workbench: Macroeconomic Data Exploration in the Cloud
In this webinar, we utilized the Posit Workbench Native App to demonstrate that macroeconomic research can be run in the Snowflake cloud, but powered by R and RStudio.
Webinar
Shifting to An Open-Source Backbone Within Clinical Trials with Roche and Genentech
Data science leaders at Roche & Genentech joined us to present the organization's shift to an open-source backbone within clinical trials. This shift is the culmination of years of preparation and innovation both within the organization and across the entire pharmaceutical industry.
Webinar
Removing the Data Obstacles in Data Science
Stop fighting your data and start using it. Watch Posit and Databricks discuss best practices for overcoming data governance hurdles and streamlining access to company assets.
Webinar
Level Up Your Data Game: Databricks + Posit Integration for R Users
See how modern sports analytics teams are transforming their workflows and how you can too.
Webinar
GSK: From Pilot Projects to Enterprise Adoption
Posit teamed up with GSK's Data Science Innovation and Engineering team to discuss how GSK, a leading pharmaceutical company, transformed its biostatistics toolkit by embracing R.
Webinar
Novo Nordisk: Journey to an R-based FDA submission
The leading pharmaceutical company behind life-changing medicines such as Ozempic, joined Posit to share their celebratory milestone in drug development - an NDA submission using open-source tooling.
Webinar
Roche's End-to-End R Journey to Submission
In the rapidly evolving landscape of pharmaceutical development, Roche showcases the use of open-source R in the regulatory submission process. In this webinar, the Roche team will share a pioneering experience of end-to-end R submission for a new drug application to the FDA, EMA, and NMPA.